The ELISpot and FluoroSpot Assay Market is valued at around USD 267.30 million in 2022 and is expected to reach USD 711.03 million by 2030, registering a CAGR of 12.7% over the forecast period. Due to its great sensitivity, the enzyme-linked immunospot (ELISpot) assay is frequently used to diagnose a variety of medical problems. They are frequently used to measure antigen-specific T cells in mice and people and are exceedingly versatile.
Read More: https://wemarketresearch.com/r....eports/elispot-and-f
כמו
תגובה
לַחֲלוֹק
